Surgical & Cosmetic Dermatology is an interdisciplinary open-access journal dedicated to publishing research on all aspects of Dermatologic Surgery. It also welcomes articles in Dermatologic and Cosmetic Surgery, Cutaneous Oncology, Images in Dermatology, Cosmetic Dermatology, Laser and Others Technologies in Dermatology
The journal adopts the continuous publication model. It means that the manuscript is released online as soon as it is ready to be published, creating a rapid flow of quality articles and resulting in faster access.
Submission of a paper to Surgical & Cosmetic Dermatology implies that all authors have read and agreed to its content, that the manuscript conforms to the journal’s policies, and that it has not been previously published or is not currently being considered for publication elsewhere.
It is also worth considering that Surgical & Cosmetic Dermatology supports the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. (http://www.icmje.org/recommendations/)
It is also worth considering that Surgical & Cosmetic Dermatology supports the:
All submitted manuscripts must be in English and Portuguese (just for Portuguese language authors). The text must be submitted in grammatically correct English to facilitate proper peer reviewing. If the authors are not native English speakers, we recommend that the manuscript is professionally edited before submission or read by a native English-speaking colleague.
Surgical & Cosmetic Dermatology is a fully open access journal. All articles are made freely and permanently available online immediately upon publication, without subscription charges or registration requirements for readers.
The journal believes that immediate and unrestricted access to scientific research promotes the global exchange of knowledge, increases the visibility and impact of scholarly work, and contributes to advances in dermatology and related fields.
All articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits anyone to read, download, copy, distribute, print, search, link to, and reuse the published material for any lawful purpose, including commercial use, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes made are indicated.
The journal does not impose any embargo period. All content is freely accessible immediately upon publication through the journal's website.
To ensure the long-term availability of the scholarly record, Surgical & Cosmetic Dermatology is committed to the digital preservation of its published content through recognized archiving and preservation services.
Open access publication is supported by Brazilian Society of Dermatology and Brazilian Society of Dermatologic Surgery. So, the authors will not need to pay any Article Processing Charge (APC) for accepted and published articles.
Authors are expected to fulfill the four criteria established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html):
(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
(2) Drafting the work or revising it critically for important intellectual content;
(3) Final approval of the version to be published;
(4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors that do not meet the criteria for authorship should be listed in the ‘Acknowledgements’ section. Each author must describe their role in the manuscript. The corresponding author is responsible for ensuring that all authors have agreed to the submission of the manuscript, but all of them should take responsibility for its content.
The list of authors should be carefully analyzed when submitting the manuscript. Any change (addition or removal of authors) during the evaluation process must have a reasonable and robust explanation in addition to a signed agreement of all authors. Authorship changes are not allowed after acceptance of the article.
This journal operates a double-anonymized peer review process (in which neither authors nor reviewers are aware of each other’s identities) in order to minimize bias. Each submission is initially evaluated by the Editor-in-Chief and co-editors to determine its suitability for publication. Manuscripts may be rejected without external peer review if they fall outside the journal’s scope, are of insufficient quality, or lack essential sections.
If the manuscript is considered appropriate, it will be assigned to one of the editors (Editor-in-Chief or Co-editors), who will forward it to at least two members of the editorial board for independent expert evaluation of its scientific merit. The final decision regarding acceptance or rejection is made by the editors after consideration of the reviewers’ comments. Possible decisions include acceptance, minor revision, major revision, or rejection. In cases where minor or major revisions are requested, failure to adequately address the reviewers’ comments may result in rejection at the editor’s discretion.
Editors do not participate in decision-making for manuscripts that they have authored, that have been written by family members or colleagues, or that concern products or services in which they have a personal interest. Such submissions are processed according to the journal’s standard procedures, with peer review conducted independently of the editor concerned and their research team.
If an author believes that a rejection decision was made in error, an appeal may be submitted. To initiate an appeal, the author must send a letter by email to the Editor, clearly outlining the grounds for reconsideration. The appeal will be reviewed by a member of the Editorial Board (jointly nominated by the Editor-in-Chief and Co-Editors) who had no involvement in the initial decision. Only one appeal per manuscript decision will be evaluated.
All content published by the journal, unless otherwise indicated, is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
This license permits anyone to read, download, copy, distribute, print, share, adapt, remix, and reuse the published material for any purpose, including commercial use, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes made are indicated.
The CC BY 4.0 license is the most accommodating of the Creative Commons licenses and is recommended for maximizing the dissemination, reuse, and impact of scholarly work. More information is available at: https://creativecommons.org/licenses/by/4.0/.
When reporting on a study that involves human subjects or human material, authors must declare that they had obtained approval from an ethics committee before undertaking the research. The article should cite a statement including the project identification code, date of acceptance, and name of the ethics committee or institutional review board.
Clinical trials or randomized controlled trials must be registered in a primary record of the WHO International Clinical Trials Registry Platform (https://www.who.int/clinical-trials-registry-platform).
Any experimental work using animals must conform to the principles of animal welfare in experimental science. Reference must be made to principles of laboratory animal care or similar regulations. The article must include the approval by a properly constituted research ethics committee containing the following data: project identification code, date of acceptance, and name of the ethics committee or institutional review board.
Authors must ensure that the reported research is not the result of misconduct such as data fabrication, falsification, plagiarism, or duplication. In case of confirmed misconduct, the journal will issue a retraction notice to correct the scientific record. All manuscripts are submitted to plagiarism detection software to prevent misconduct and ensure written work's originality.
Upon acceptance and publication of a manuscript, the authors transfer the copyright of the work to the Sociedade Brasileira de Dermatologia (SBD), the legal publisher of Surgical & Cosmetic Dermatology.
The copyright transfer grants the SBD the exclusive right to publish, reproduce, distribute, archive, and communicate the article in all forms and media, whether existing now or developed in the future.
Authors retain the right to use their published material for academic and educational purposes, including inclusion in theses, dissertations, books, institutional repositories, and presentations, provided that full and proper citation to the original publication in Surgical & Cosmetic Dermatology is included.
All content the journal, except where identified, under the Creative Commons Attribution 4.0 International licence - ISSN-e 1984-8773
